TipRanks
Biofrontera AG (DE:B8FK)
XETRA:B8FK
Germany Market
B8FK
Biofrontera
RESEARCH TOOLSreports
Want to see DE:B8FK full AI Analyst Report?

Biofrontera (B8FK) Income Statement

3 Followers

Biofrontera Income Statement

Last quarter (Q4 2023), Biofrontera's total revenue was €7.45M, an increase of 28.47% from the same quarter last year. In Q4, Biofrontera's net income was €5.92M. See Biofrontera’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Mar 23Mar 22
Total Revenue
€ 13.19M€ 12.18M€ 32.25M€ 25.74M€ 28.79M
Gross Profit
€ 10.91M€ 10.12M€ 25.37M€ 20.98M€ 24.87M
Operating Expenses
€ 11.93M€ 11.70M€ 20.59M€ 19.39M€ 60.21M
Depreciation and Amortization
€ 648.00K€ 839.00K€ 791.00K€ 746.00K€ 3.29M
EBITDA
€ -560.00K€ -301.00K€ 5.57M€ 2.34M€ -12.59M
Operating Income
€ -1.02M€ -1.59M€ 4.78M€ 1.59M€ -35.34M
Other Income/Expenses
€ -197.00K€ 436.00K€ -6.91M€ -44.80M€ 71.02M
Pretax Income
€ -1.22M€ -1.15M€ -2.13M€ -43.21M€ 35.68M
Net Income
€ -3.96M€ -4.35M€ -369.00K€ -44.17M€ 37.75M
Per Share Metrics
Basic EPS
€ -0.65€ -0.72€ >-0.01€ -0.77€ 0.66
Diluted EPS
€ -0.65€ -0.72€ >-0.01€ -0.77€ 0.65
Weighted Average Shares Outstanding
 6.08M 6.08M 63.81M 57.47M 57.90M
Weighted Average Shares Outstanding (Diluted)
 6.08M 6.08M 63.81M 57.47M 59.29M
Currency in EUR

Biofrontera Earnings and Revenue History